All Stories

  1. The predictive power of the microbiome exceeds that of genome-wide association studies in the discrimination of complex human disease
  2. The Landscape of Genetic Content in the Gut and Oral Human Microbiome
  3. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences
  4. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism
  5. Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis
  6. A perfect storm: Genetics and anticommensal antibodies shore up type 1 diabetes
  7. The Crohn’s disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response
  8. Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States
  9. Correction for Zhao et al., Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children
  10. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status
  11. Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites
  12. Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing
  13. Aether: leveraging linear programming for optimal cloud computing in genomics
  14. Aether: Leveraging Linear Programming For Optimal Cloud Computing In Genomics
  15. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children
  16. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue
  17. Gut Microbiota: Small Molecules Modulate Host Cellular Functions
  18. A Microbiome Foundation for the Study of Crohn’s Disease
  19. Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease
  20. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
  21. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease
  22. The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
  23. Research Highlights
  24. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
  25. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
  26. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
  27. Fusobacterium nucleatumand T Cells in Colorectal Carcinoma
  28. An Integrative View of Microbiome-Host Interactions in Inflammatory Bowel Diseases
  29. The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
  30. Inflammatory Bowel Disease as a Model for Translating the Microbiome
  31. The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
  32. The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
  33. Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response
  34. Microbes and Inflammation in Colorectal Cancer
  35. Sequence-Based Discovery ofBradyrhizobium entericain Cord Colitis Syndrome
  36. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
  37. Exploring host-microbiota interactions in animal models and humans
  38. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
  39. Keystone microbiome meeting 2012: a mountain top experience
  40. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
  41. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
  42. PathSeq: software to identify or discover microbes by deep sequencing of human tissue
  43. The TPR-containing domain within Est1 homologs exhibits species-specific roles in telomerase interaction and telomere length homeostasis